| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,793 |
5,669 |
$246K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,348 |
768 |
$47K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
585 |
444 |
$45K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,201 |
1,174 |
$39K |
| 88307 |
|
598 |
537 |
$31K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,198 |
1,171 |
$22K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
693 |
681 |
$10K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
141 |
138 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
519 |
390 |
$3K |
| 88342 |
|
319 |
260 |
$3K |
| 88304 |
|
155 |
143 |
$3K |
| 88341 |
|
80 |
63 |
$2K |
| 87481 |
|
16 |
15 |
$2K |
| 85060 |
|
124 |
105 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
51 |
50 |
$768.48 |
| 88112 |
|
24 |
14 |
$170.45 |
| 81513 |
|
26 |
22 |
$0.00 |